NCT00019513View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

PHASE1CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

August 31, 1998

Study Completion Date

June 30, 2004

Conditions

Colorectal CancerEsophageal CancerExtrahepatic Bile Duct CancerGallbladder CancerLiver CancerLung CancerLymphomaPancreatic CancerSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

fluorouracil

DRUG

gemcitabine hydrochloride

DRUG

leucovorin calcium

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00019513 - Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | Biotech Hunter | Biotech Hunter